{"transactions":[{"id":761519,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T19:20:49.000Z","date":"2026-05-26","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.429,"value":2145.0,"ownership":{"direct":true},"balance_after":5593,"source":{"system":"sec-edgar","filing":"0001649989-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000164998926000002/primary_doc.xml","form_type":"4"}},{"id":1024288,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T23:00:18.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":286734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant is an annual stock option grant under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the \"2024 Plan\") and shall fully vest on October 1, 2026, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":286734,"derivative":{"exercise_price":1.04,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":286734},"source":{"system":"sec-edgar","filing":"0001649989-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000164998925000004/primary_doc.xml","form_type":"4"}},{"id":1391656,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-04T00:30:05.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":89549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant was made under the 2024 Plan and shall fully vest on October 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":89549,"derivative":{"exercise_price":5.22,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":89549},"source":{"system":"sec-edgar","filing":"0001415889-24-024701","document":"form4-10032024_081001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000141588924024701/form4-10032024_081001.xml","form_type":"4"}},{"id":1391655,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-04T00:30:05.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":56636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant is an annual stock option grant under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the \"2024 Plan\") and shall fully vest on October 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":56636,"derivative":{"exercise_price":5.22,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":56636},"source":{"system":"sec-edgar","filing":"0001415889-24-024701","document":"form4-10032024_081001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000141588924024701/form4-10032024_081001.xml","form_type":"4"}},{"id":1586330,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-08T21:04:31.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":94441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall fully vest on the earlier of (i) March 7, 2025; or (ii) the date of the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":94441,"derivative":{"exercise_price":0.41,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":94441},"source":{"system":"sec-edgar","filing":"0001415889-24-007319","document":"form4-03082024_090322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000141588924007319/form4-03082024_090322.xml","form_type":"4"}},{"id":1933821,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T21:44:43.000Z","date":"2023-03-29","kind":"grant","planned":false,"acquired":true,"shares":41065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall fully vest on the earlier of (i) March 29,2024; or (ii) the date of the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":41065,"derivative":{"exercise_price":1.05,"expiration_date":"2033-03-29","underlying":"Common Stock","underlying_shares":41065},"source":{"system":"sec-edgar","filing":"0001209191-23-021905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919123021905/doc4.xml","form_type":"4"}},{"id":2148609,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-09-30T21:20:51.000Z","date":"2022-09-29","kind":"exercise","acquired":false,"shares":40255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options."}],"balance_after":84670,"derivative":{"exercise_price":2.5,"exercise_date":"2019-04-11","expiration_date":"2029-04-11","underlying":"Common Stock","underlying_shares":40255},"source":{"system":"sec-edgar","filing":"0001213900-22-060782","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390022060782/ownership.xml","form_type":"4"}},{"id":2148608,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-30T21:20:51.000Z","date":"2022-09-29","kind":"sale","acquired":false,"shares":40255,"price":4.29,"value":172693.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold in the open market in multiple transactions at prices ranging from $4.18 to $4.57. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to TFF Pharmaceuticals, Inc., any stockholder of TFF Pharmaceuticals, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported shares were sold in the open market in multiple transactions at prices ranging from $4.18 to $4.57. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to TFF Pharmaceuticals, Inc., any stockholder of TFF Pharmaceuticals, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-22-060782","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390022060782/ownership.xml","form_type":"4"}},{"id":2148607,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-30T21:20:51.000Z","date":"2022-09-29","kind":"exercise","acquired":true,"shares":40255,"price":2.5,"value":100637.5,"ownership":{"direct":true},"balance_after":40255,"source":{"system":"sec-edgar","filing":"0001213900-22-060782","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390022060782/ownership.xml","form_type":"4"}},{"id":2318703,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-24T21:36:52.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":81878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall fully vest on the earlier of (i) March 23,2023; or (ii) the date of the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control."}],"balance_after":81878,"derivative":{"exercise_price":1.92,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":81878},"source":{"system":"sec-edgar","filing":"0001209191-22-020949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919122020949/doc4.xml","form_type":"4"}},{"id":2705106,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T20:05:44.000Z","date":"2021-05-18","kind":"purchase","acquired":true,"shares":1050,"price":9.4,"value":9870.0,"ownership":{"direct":true},"balance_after":1050,"source":{"system":"sec-edgar","filing":"0001213900-21-027899","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390021027899/ownership.xml","form_type":"4"}},{"id":2770377,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-26T22:06:39.000Z","date":"2021-03-24","kind":"grant","acquired":true,"shares":20873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall vest in full on March 24, 2022, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event."}],"balance_after":20873,"derivative":{"exercise_price":2.27,"expiration_date":"2031-03-24","underlying":"Common Stock","underlying_shares":20873},"source":{"system":"sec-edgar","filing":"0001209191-21-023279","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919121023279/doc4.xml","form_type":"4"}},{"id":2980838,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-11-14T02:01:06.000Z","date":"2020-11-11","kind":"exercise","acquired":false,"shares":34504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"23,003 shares of common stock vested on April 11, 2020 and the remainder of shares scheduled to vest at an approximate rate of 5,750 every three months thereafter."}],"balance_after":124925,"derivative":{"exercise_price":2.5,"exercise_date":"2020-04-11","expiration_date":"2029-04-11","underlying":"Common Stock","underlying_shares":34504},"source":{"system":"sec-edgar","filing":"0001213900-20-037060","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390020037060/ownership.xml","form_type":"4"}},{"id":2980837,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-14T02:01:06.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":5000,"price":17.173,"value":85865.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-20-037060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390020037060/ownership.xml","form_type":"4"}},{"id":2980836,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-14T02:01:06.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":34504,"price":15.908,"value":548889.632,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001213900-20-037060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390020037060/ownership.xml","form_type":"4"}},{"id":2980835,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-14T02:01:06.000Z","date":"2020-11-11","kind":"exercise","acquired":true,"shares":34504,"price":2.5,"value":86260.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options."}],"balance_after":39504,"source":{"system":"sec-edgar","filing":"0001213900-20-037060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390020037060/ownership.xml","form_type":"4"}},{"id":3012805,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-05T22:44:44.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":396809,"price":0.5141,"value":203999.5069,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted under the 2015 Plan in lieu of $204,000 cash fees payable under the Issuer's non-employee Director compensation program and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan."}],"balance_after":396809,"derivative":{"exercise_price":0.7052,"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":396809},"source":{"system":"sec-edgar","filing":"0001209191-20-053870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919120053870/doc4.xml","form_type":"4"}},{"id":3012804,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-05T22:44:44.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":259297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall vest in full on October 1, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event."}],"balance_after":259297,"derivative":{"exercise_price":0.71,"expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":259297},"source":{"system":"sec-edgar","filing":"0001209191-20-053870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919120053870/doc4.xml","form_type":"4"}},{"id":3027973,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-17T23:20:01.000Z","date":"2020-07-17","kind":"grant","acquired":true,"shares":154555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall vest in full on July 17, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event."}],"balance_after":154555,"derivative":{"exercise_price":1.58,"expiration_date":"2030-07-17","underlying":"Common Stock","underlying_shares":154555},"source":{"system":"sec-edgar","filing":"0001209191-20-051048","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919120051048/doc4a.xml","form_type":"4/A","original_submission_date":"2020-07-21"}},{"id":3031156,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-15T22:31:19.000Z","date":"2020-09-14","kind":"purchase","acquired":true,"shares":10000,"price":0.62,"value":6200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.62 to $0.625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a 1-for-8 reverse stock split effected by the Issuer on March 15, 2019 (the \"Split Date\"). The Reporting Person's previous ownership of 15,000 shares of common stock was adjusted to 1,875 shares of Common Stock on the Split Date."}],"balance_after":11875,"source":{"system":"sec-edgar","filing":"0001209191-20-050564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919120050564/doc4.xml","form_type":"4"}},{"id":3046148,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-26T22:16:55.000Z","date":"2020-08-24","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Option shall vest and first become exercisable as follows: one-quarter of the Option shall vest and first become exercisable on August 24, 2021 and the remainder of the Option shall vest and first become exercisable in 12 equal quarterly installments commencing on November 24, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Option shall vest and first become exercisable as follows: one-quarter of the Option shall vest and first become exercisable on August 24, 2021 and the remainder of the Option shall vest and first become exercisable in 12 equal quarterly installments commencing on November 24, 2021."}],"balance_after":159429,"derivative":{"exercise_price":13.65,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-20-023901","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390020023901/ownership.xml","form_type":"4"}},{"id":3078632,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-21T22:11:40.000Z","date":"2020-07-17","kind":"grant","acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall vest in full on July 17, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event."}],"balance_after":210000,"derivative":{"exercise_price":1.58,"expiration_date":"2030-07-17","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001209191-20-043228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919120043228/doc4.xml","form_type":"4"}},{"id":3199117,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-20T21:52:00.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall vest in full on March 19, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event."}],"balance_after":15000,"derivative":{"exercise_price":0.54,"expiration_date":"2030-03-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-020508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919120020508/doc4.xml","form_type":"4"}},{"id":3353817,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-12-04T00:42:05.000Z","date":"2019-11-29","kind":"grant","acquired":true,"shares":3623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years."}],"balance_after":139429,"derivative":{"exercise_price":5,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":3623},"source":{"system":"sec-edgar","filing":"0001213900-19-025249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390019025249/ownership.xml","form_type":"4"}},{"id":3386157,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-10-30T00:32:34.000Z","date":"2019-10-29","kind":"grant","acquired":true,"shares":43794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years."}],"balance_after":135806,"derivative":{"exercise_price":5,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":43794},"source":{"system":"sec-edgar","filing":"0001213900-19-021424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390019021424/ownership.xml","form_type":"4"}},{"id":3386156,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T00:32:34.000Z","date":"2019-10-25","kind":"purchase","acquired":true,"shares":5000,"price":5,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock purchased in the Issuer's initial public offering."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001213900-19-021424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000121390019021424/ownership.xml","form_type":"4"}},{"id":3396582,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-07T22:08:57.000Z","date":"2019-10-03","kind":"grant","acquired":true,"shares":207036,"price":0.9853,"value":203992.5708,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted under the 2015 Plan in lieu of $204,000 cash fees payable under the Issuer's non-employee Director compensation program and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2020, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan."}],"balance_after":207036,"derivative":{"exercise_price":1.4,"expiration_date":"2029-10-03","underlying":"Common Stock","underlying_shares":207036},"source":{"system":"sec-edgar","filing":"0001209191-19-052709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919119052709/doc4.xml","form_type":"4"}},{"id":3396581,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-07T22:08:57.000Z","date":"2019-10-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2015 Equity Incentive Plan (the \"2015 Plan\") and shall vest in full on the one year anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan."}],"balance_after":15000,"derivative":{"exercise_price":1.4,"expiration_date":"2029-10-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-052709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919119052709/doc4.xml","form_type":"4"}},{"id":3720828,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T22:17:43.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":15000,"price":0.6834,"value":10251.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.63 - $0.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-18-063966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919118063966/doc4.xml","form_type":"4"}},{"id":3766485,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-13T21:55:14.000Z","date":"2018-11-09","kind":"grant","acquired":true,"shares":567522,"price":0.613,"value":347890.986,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued to the Reporting Person pursuant to the Issuer's 2015 Equity Incentive Plan in lieu of two years of cash retainer and meeting fees, including Executive Chairman fee, of $348,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":567522,"derivative":{"exercise_price":0.89,"expiration_date":"2028-11-09","underlying":"Common Stock","underlying_shares":567522},"source":{"system":"sec-edgar","filing":"0001209191-18-058302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919118058302/doc4.xml","form_type":"4"}},{"id":3808116,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-25T21:00:10.000Z","date":"2018-09-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest on September 21, 2019, subject to the Reporting Person providing continuous service to the Issuer on such date."}],"balance_after":15000,"derivative":{"exercise_price":0.9155,"expiration_date":"2028-09-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-052159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919118052159/doc4.xml","form_type":"4"}},{"id":3881256,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-28T21:19:27.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33.33% of the shares underlying the option shall vest on each of the first, second and third anniversaries of the grant date, such that 100% of the shares underlying the option shall be vested on June 27, 2021, subject to the Reporting Person providing continued service through such date."}],"balance_after":100000,"derivative":{"exercise_price":0.88,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-18-039938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919118039938/doc4.xml","form_type":"4"}},{"id":3961922,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-17T21:05:09.000Z","date":"2018-04-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33.33% of the shares underlying the option shall vest on each of the first, second and third anniversaries of the grant date, such that 100% of the shares underlying the option shall be vested on April 13, 2021, subject to the Reporting Person providing continued service through such date."}],"balance_after":25000,"derivative":{"exercise_price":0.92,"expiration_date":"2028-04-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-025216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000120919118025216/doc4.xml","form_type":"4"}},{"id":4306669,"issuer":{"id":13670,"kind":"organization","name":"Veradigm Inc.","symbol":"MDRX"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-24T20:45:44.000Z","date":"2017-05-22","kind":"grant","acquired":true,"shares":16765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units award with vesting that will occur in twelve (12) equal monthly installments, commencing in June 2017.  Distribution of the vested units is deferred pursuant to the Allscripts Healthcare Solutions, Inc. Director Deferred Compensation Plan."}],"balance_after":105014,"source":{"system":"sec-edgar","filing":"0001209191-17-035000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124804/000120919117035000/doc4.xml","form_type":"4"}},{"id":4374596,"issuer":{"id":160670,"kind":"organization","name":"Presbia PLC","symbol":"LENS"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2017-03-22T21:01:25.000Z","date":"2017-03-13","kind":"grant","acquired":true,"shares":12738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 13, 2017, the Reporting Person was granted 12,738 restricted ordinary shares, which vest on March 13, 2018."}],"balance_after":45924,"source":{"system":"sec-edgar","filing":"0000905718-17-000378","document":"thurman_fm4mar132017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000090571817000378/thurman_fm4mar132017.xml","form_type":"4"}},{"id":4390550,"issuer":{"id":160670,"kind":"organization","name":"Presbia PLC","symbol":"LENS"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Subscription Rights (right to buy)","published_at":"2017-03-10T21:05:24.000Z","date":"2017-03-08","kind":"other","acquired":false,"shares":16533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Each subscription right entitled its holder to purchase 0.335297256 Ordinary Shares at a subscription price of $3.00 per whole Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":3,"exercise_date":"2017-02-06","expiration_date":"2017-03-08","underlying":"Ordinary Shares","underlying_shares":5543},"source":{"system":"sec-edgar","filing":"0000905718-17-000331","document":"thurman_fm4mar102017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000090571817000331/thurman_fm4mar102017.xml","form_type":"4"}},{"id":4390549,"issuer":{"id":160670,"kind":"organization","name":"Presbia PLC","symbol":"LENS"},"owners":[{"id":43781,"kind":"person","name":"THURMAN RANDY H","position":1,"cik":"0001204059","reported_name":"THURMAN RANDY H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2017-03-10T21:05:24.000Z","date":"2017-03-08","kind":"other","acquired":true,"shares":5543,"price":3,"value":16629.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 8, 2017, the Reporting Person delivered to the Issuer an irrevocable notice of exercise of his subscription rights to purchase 5,543 Ordinary Shares, together with payment of the requisite fee, pursuant to the rights offering set forth in the Prospectus filed pursuant to Rule 424(b)(4), filed with the SEC on January 27, 2017, as amended February 23, 2017."}],"balance_after":33186,"source":{"system":"sec-edgar","filing":"0000905718-17-000331","document":"thurman_fm4mar102017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204059/000090571817000331/thurman_fm4mar102017.xml","form_type":"4"}}]}